Public
attitudes regarding willingness to participate in medical
research studies.
Trauth
JM et al. J Health Soc Policy 2000;12(2):23-43.
Factors
that influence a patient's decision to participate in a phase
I cancer clinical trial.
Schutta
KM, Burnett CB. Oncol Nurs Forum 2000;27(9):1435-8.
Attitudes
towards and participation in randomised clinical trials in
oncology: a review of the literature.
Ellis
PM. Ann Oncol 2000;11(8):939-45.
Patients'
perceptions of physicians communication and outcomes of the
accrual to trial process.
Grant
CH 3rd et al. Health Commun 2000;12(1):23-39.
Patient
participation in research in the managed care environment:
key perceptions of members in an HMO.
Purdy S et al. J Gen Intern Med 2000 ;15(7):492-5.
Information
presentation and decisions to enter clinical trials: a hypothetical
trial of hormone replacement therapy.
Wragg
JA et al. Soc Sci Med 2000;51(3):453-62.
Proposing
phase I studies: patients', relatives', nurses' and specialists'
perceptions.
Tomamichel
M et al. Ann Oncol 2000;11(3):289-94.
Racial
disparities in participation in biomedical research.
Kressin
NR et al. J Natl Med Assoc 2000;92(2):62-9.
African-American
attitudes regarding cancer clinical trials and research studies:
results from focus group methodology.
Green
BL et al. Ethn Dis 2000;10(1):76-86.
What
influences participation in clinical trials in palliative
care in a cancer centre?
Ling
J et al. Eur J Cancer 2000;36(5):621-6.
Incorporating
patient preferences into randomized trials.
Lambert
MF, Wood J. J Clin Epidemiol 2000;53(2):163-6.
Factors
that predict the referral of breast cancer patients onto clinical
trials by their surgeons and medical oncologists.
Siminoff
LA et al. J Clin Oncol 2000;18(6):1203-11.
Cost
of care for patients in cancer clinical trials.
Fireman
BH et al. J Natl Cancer Inst 2000;92(2):136-42.
|